• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲国家间非传染性疾病负担的不平等:对 2019 年全球疾病负担研究的系统分析。

Inequalities in the burden of non-communicable diseases across European countries: a systematic analysis of the Global Burden of Disease 2019 study.

机构信息

Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, 26 Kassai Street, 4028, Debrecen, Hungary.

Faculty of Medicine, University of Basel, Basel, Switzerland.

出版信息

Int J Equity Health. 2023 Jul 28;22(1):140. doi: 10.1186/s12939-023-01958-8.

DOI:10.1186/s12939-023-01958-8
PMID:
37507733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10375608/
Abstract

BACKGROUND

Although overall health status in the last decades improved, health inequalities due to non-communicable diseases (NCDs) persist between and within European countries. There is a lack of studies giving insights into health inequalities related to NCDs in the European Economic Area (EEA) countries. Therefore, the aim of the present study was to quantify health inequalities in age-standardized disability adjusted life years (DALY) rates for NCDs overall and 12 specific NCDs across 30 EEA countries between 1990 and 2019. Also, this study aimed to determine trends in health inequalities and to identify those NCDs where the inequalities were the highest.

METHODS

DALY rate ratios were calculated to determine and compare inequalities between the 30 EEA countries, by sex, and across time. Annual rate of change was used to determine the differences in DALY rate between 1990 and 2019 for males and females. The Gini Coefficient (GC) was used to measure the DALY rate inequalities across countries, and the Slope Index of Inequality (SII) to estimate the average absolute difference in DALY rate across countries.

RESULTS

Between 1990 and 2019, there was an overall declining trend in DALY rate, with larger declines among females compared to males. Among EEA countries, in 2019 the highest NCD DALY rate for both sexes were observed for Bulgaria. For the whole period, the highest DALY rate ratios were identified for digestive diseases, diabetes and kidney diseases, substance use disorders, cardiovascular diseases (CVD), and chronic respiratory diseases - representing the highest inequality between countries. In 2019, the highest DALY rate ratio was found between Bulgaria and Iceland for males. GC and SII indicated that the highest inequalities were due to CVD for most of the study period - however, overall levels of inequality were low.

CONCLUSIONS

The inequality in level 1 NCDs DALYs rate is relatively low among all the countries. CVDs, digestive diseases, diabetes and kidney diseases, substance use disorders, and chronic respiratory diseases are the NCDs that exhibit higher levels of inequality across countries in the EEA. This might be mitigated by applying tailored preventive measures and enabling healthcare access.

摘要

背景

尽管过去几十年的整体健康状况有所改善,但欧洲国家之间和内部仍存在着与非传染性疾病(NCDs)相关的健康不平等。缺乏研究深入了解欧洲经济区(EEA)国家与 NCD 相关的健康不平等。因此,本研究的目的是量化 30 个 EEA 国家在 NCD 总发病率和 12 种特定 NCD 发病率的标准化残疾调整生命年(DALY)率方面的健康不平等程度。此外,本研究旨在确定健康不平等的趋势,并确定那些 NCD 不平等程度最高的疾病。

方法

通过性别和时间计算 DALY 率比来确定和比较 30 个 EEA 国家之间的不平等程度。使用年度变化率来确定 1990 年至 2019 年男性和女性 DALY 率之间的差异。基尼系数(GC)用于衡量国家间 DALY 率的不平等程度,斜率指数(SII)用于估计国家间 DALY 率的平均绝对差异。

结果

1990 年至 2019 年,DALY 率呈总体下降趋势,女性的下降幅度大于男性。在 EEA 国家中,2019 年两性发病率最高的 NCD DALY 率是保加利亚。在整个研究期间,发病率最高的 DALY 率比见于消化疾病、糖尿病和肾脏疾病、物质使用障碍、心血管疾病(CVD)和慢性呼吸道疾病——这代表了国家间最高的不平等。2019 年,保加利亚和冰岛男性 DALY 率比最高。GC 和 SII 表明,在研究期间的大部分时间里,心血管疾病导致了最高的不平等——然而,总体不平等水平较低。

结论

在所有国家中,一级 NCD DALY 率的不平等程度相对较低。心血管疾病、消化疾病、糖尿病和肾脏疾病、物质使用障碍以及慢性呼吸道疾病是 EEA 国家间表现出更高不平等水平的 NCD。通过应用有针对性的预防措施和提供医疗保健服务,可以缓解这一情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b5/10375608/40a66c643494/12939_2023_1958_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b5/10375608/244b2e59ffeb/12939_2023_1958_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b5/10375608/6dd02af7064f/12939_2023_1958_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b5/10375608/af5f2c6e8e8b/12939_2023_1958_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b5/10375608/a72e9b655c23/12939_2023_1958_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b5/10375608/87a29284a521/12939_2023_1958_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b5/10375608/40a66c643494/12939_2023_1958_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b5/10375608/244b2e59ffeb/12939_2023_1958_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b5/10375608/6dd02af7064f/12939_2023_1958_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b5/10375608/af5f2c6e8e8b/12939_2023_1958_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b5/10375608/a72e9b655c23/12939_2023_1958_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b5/10375608/87a29284a521/12939_2023_1958_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b5/10375608/40a66c643494/12939_2023_1958_Fig6_HTML.jpg

相似文献

1
Inequalities in the burden of non-communicable diseases across European countries: a systematic analysis of the Global Burden of Disease 2019 study.欧洲国家间非传染性疾病负担的不平等:对 2019 年全球疾病负担研究的系统分析。
Int J Equity Health. 2023 Jul 28;22(1):140. doi: 10.1186/s12939-023-01958-8.
2
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、地区和国家残疾调整生命年(DALYs)用于 333 种疾病和伤害以及 195 个国家和地区的健康期望寿命(HALE),1990-2016 年:全球疾病负担研究 2016 年的系统分析。
Lancet. 2017 Sep 16;390(10100):1260-1344. doi: 10.1016/S0140-6736(17)32130-X.
3
Global socioeconomic inequality in the burden of communicable and non-communicable diseases and injuries: an analysis on global burden of disease study 2019.全球传染病和非传染性疾病及伤害负担的社会经济不平等状况:2019 年全球疾病负担研究分析。
BMC Public Health. 2021 Sep 28;21(1):1771. doi: 10.1186/s12889-021-11793-7.
4
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.1990 - 2013年全球、区域和国家306种疾病和损伤的伤残调整生命年(DALYs)以及188个国家的健康预期寿命(HALE):量化流行病学转变
Lancet. 2015 Nov 28;386(10009):2145-91. doi: 10.1016/S0140-6736(15)61340-X. Epub 2015 Aug 28.
5
Burden of non-communicable diseases in sub-Saharan Africa, 1990-2017: results from the Global Burden of Disease Study 2017.撒哈拉以南非洲地区非传染性疾病负担,1990-2017 年:2017 年全球疾病负担研究结果。
Lancet Glob Health. 2019 Oct;7(10):e1375-e1387. doi: 10.1016/S2214-109X(19)30374-2.
6
Nations within a nation: variations in epidemiological transition across the states of India, 1990-2016 in the Global Burden of Disease Study.一国之内的差异:1990-2016 年印度各邦的疾病流行转变的流行病学差异,全球疾病负担研究。
Lancet. 2017 Dec 2;390(10111):2437-2460. doi: 10.1016/S0140-6736(17)32804-0. Epub 2017 Nov 14.
7
Evolving trends, regional differences, determinants, and disease sources of provincial-level health inequalities in china 1990-2019: a temporal convergence and novel triple decomposition analysis.中国省级卫生不平等的演变趋势、区域差异、决定因素和疾病来源 1990-2019:时间收敛和新的三重分解分析。
Int J Equity Health. 2024 Oct 8;23(1):203. doi: 10.1186/s12939-024-02283-4.
8
Burden of non-communicable diseases among adolescents aged 10-24 years in the EU, 1990-2019: a systematic analysis of the Global Burden of Diseases Study 2019.欧盟 10-24 岁青少年人群的非传染性疾病负担:2019 年全球疾病负担研究的系统分析。
Lancet Child Adolesc Health. 2022 Jun;6(6):367-383. doi: 10.1016/S2352-4642(22)00073-6. Epub 2022 Mar 24.
9
Disability-Adjusted Life-Years (DALYs) for 315 Diseases and Injuries and Healthy Life Expectancy (HALE) in Iran and its Neighboring Countries, 1990-2015: Findings from Global Burden of Disease Study 2015.1990 - 2015年伊朗及其邻国315种疾病和损伤的伤残调整生命年(DALYs)及健康预期寿命(HALE):全球疾病负担研究2015的结果
Arch Iran Med. 2017 Jul;20(7):403-418.
10
Temporal trends in the burden of non-communicable diseases in countries with the highest malaria burden, 1990-2019: Evaluating the double burden of non-communicable and communicable diseases in epidemiological transition.1990-2019 年疟疾负担最高国家的非传染性疾病负担的时间趋势:评估传染病和非传染病在流行病学转变中的双重负担。
Global Health. 2022 Oct 23;18(1):90. doi: 10.1186/s12992-022-00882-w.

引用本文的文献

1
Highlights from the Manifesto on the Health Economics of Cardiovascular Disease Prevention.《心血管疾病预防健康经济学宣言》要点
Pharmacoeconomics. 2025 Sep 8. doi: 10.1007/s40273-025-01537-5.
2
The global burden of depression attributable to childhood sexual abuse, intimate partner violence, and bullying victimization from 1990 to 2021: an analysis based on the global burden of disease study.1990年至2021年期间,童年期性虐待、亲密伴侣暴力和受欺凌所致抑郁症的全球负担:基于全球疾病负担研究的分析
Ann Gen Psychiatry. 2025 Aug 6;24(1):47. doi: 10.1186/s12991-025-00586-6.
3
Adolescent understanding of concepts related to the developmental origins of health and disease: a Pacific perspective.

本文引用的文献

1
How the European Union legislations are tackling the burden of diabetes mellitus: A legal surveillance study.欧盟立法如何应对糖尿病负担:一项法律监测研究。
Front Public Health. 2022 Nov 23;10:1002265. doi: 10.3389/fpubh.2022.1002265. eCollection 2022.
2
The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study.中欧、东欧和西欧次区域的伤害负担:来自《2019年全球疾病负担研究》的系统分析
Arch Public Health. 2022 May 20;80(1):142. doi: 10.1186/s13690-022-00891-6.
3
Burden of non-communicable diseases among adolescents aged 10-24 years in the EU, 1990-2019: a systematic analysis of the Global Burden of Diseases Study 2019.
青少年对与健康和疾病发育起源相关概念的理解:太平洋地区视角
J R Soc N Z. 2024 Jun 19;55(6):1623-1638. doi: 10.1080/03036758.2024.2363419. eCollection 2025.
4
Impact of national and supranational policies on social inequalities in major NCDs and related risk factors in Europe: a scoping review protocol.国家和超国家政策对欧洲主要非传染性疾病及相关风险因素社会不平等现象的影响:一项范围综述方案
BMJ Open. 2025 Jul 16;15(7):e900939. doi: 10.1136/bmjopen-2025-900939.
5
The concept of biophotonic signaling in the human body and brain: rationale, problems and directions.人体和大脑中的生物光子信号传导概念:基本原理、问题与方向。
Front Syst Neurosci. 2025 Jun 23;19:1597329. doi: 10.3389/fnsys.2025.1597329. eCollection 2025.
6
Burden of hypertensive heart disease attributed to metabolic factors from 1990 to 2021 at global, regional, and national levels: an analysis of the global burden of disease study 2021.1990年至2021年全球、区域和国家层面归因于代谢因素的高血压性心脏病负担:全球疾病负担研究2021分析
Front Cardiovasc Med. 2025 May 29;12:1572392. doi: 10.3389/fcvm.2025.1572392. eCollection 2025.
7
Success factors and measures for scaling patient-facing digital health technologies from leaders' insights.基于领导者见解的扩大患者端数字健康技术应用的成功因素与措施
BMC Health Serv Res. 2025 May 1;25(1):632. doi: 10.1186/s12913-025-12748-z.
8
Mitochondrial Dysfunction and Atherosclerosis: The Problem and the Search for Its Solution.线粒体功能障碍与动脉粥样硬化:问题与解决方案探寻
Biomedicines. 2025 Apr 15;13(4):963. doi: 10.3390/biomedicines13040963.
9
Exploring health literacy development through co-design: understanding the expectations for health literacy mediators.通过共同设计探索健康素养发展:理解对健康素养调解人的期望。
Health Promot Int. 2025 Jan 17;40(1). doi: 10.1093/heapro/daaf003.
10
The burden of ischemic stroke in Eastern Europe from 1990 to 2021.1990年至2021年东欧缺血性中风的负担。
BMC Neurol. 2025 Feb 22;25(1):74. doi: 10.1186/s12883-025-04081-z.
欧盟 10-24 岁青少年人群的非传染性疾病负担:2019 年全球疾病负担研究的系统分析。
Lancet Child Adolesc Health. 2022 Jun;6(6):367-383. doi: 10.1016/S2352-4642(22)00073-6. Epub 2022 Mar 24.
4
Toward a third term of Health Japan 21 - implications from the rise in non-communicable disease burden and highly preventable risk factors.迈向“健康日本21”的第三个任期——非传染性疾病负担上升和高度可预防风险因素带来的影响
Lancet Reg Health West Pac. 2022 Apr;21:100377. doi: 10.1016/j.lanwpc.2021.100377. Epub 2022 Jan 23.
5
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.2010 年至 2019 年 29 种癌症的发病率、死亡率、生命损失年数、失能生存年数和伤残调整生命年:2019 年全球疾病负担研究的系统分析。
JAMA Oncol. 2022 Mar 1;8(3):420-444. doi: 10.1001/jamaoncol.2021.6987.
6
The Short-Term Effects of European Integration on Mortality Convergence: A Case Study of European Union's 2004 Enlargement.欧洲一体化对死亡率趋同的短期影响:以欧盟2004年东扩为例
Eur J Popul. 2021 Oct 7;37(4-5):909-931. doi: 10.1007/s10680-021-09596-y. eCollection 2021 Nov.
7
Epidemiology of cardiovascular disease in Europe.欧洲心血管疾病的流行病学。
Nat Rev Cardiol. 2022 Feb;19(2):133-143. doi: 10.1038/s41569-021-00607-3. Epub 2021 Sep 8.
8
Risk factors and their contribution to population health in the European Union (EU-28) countries in 2007 and 2017.2007 年和 2017 年欧盟(欧盟 28 国)国家的风险因素及其对人口健康的贡献。
Eur J Public Health. 2021 Oct 26;31(5):958-967. doi: 10.1093/eurpub/ckab145.
9
Progress and challenges in achieving noncommunicable diseases targets for the sustainable development goals.实现可持续发展目标中关于非传染性疾病目标的进展与挑战
FASEB Bioadv. 2021 Apr 29;3(8):563-568. doi: 10.1096/fba.2020-00117. eCollection 2021 Aug.
10
Diabetes and heart failure notions from epidemiology including patterns in low-, middle- and high-income countries.糖尿病和心力衰竭的流行病学概念,包括低收入、中等收入和高收入国家的模式。
Diabetes Res Clin Pract. 2021 Jul;177:108822. doi: 10.1016/j.diabres.2021.108822. Epub 2021 Apr 17.